Market Overview:
The global mesalamine API market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of gastrointestinal disorders, rising demand for generic drugs, and growing investments by pharmaceutical companies in R&D activities. Based on type, the global mesalamine API market is segmented into purity levels of ≥ 97%, ≥ 98%, and ≥ 99%. The purity level of > 97% is expected to dominate the market during the forecast period owing to its lower cost as compared to other purity levels. Based on application, mesalamine tablets are expected to account for a major share of the global mesalamine API market during the forecast period. However, capsules are projectedto grow at a higher CAGR due to their increasing use in various indications such as ulcerative colitis and Crohn's disease.
Product Definition:
Mesalamine API is a medication used to treat ulcerative colitis and Crohn's disease. The importance of Mesalamine API is that it helps reduce inflammation in the gastrointestinal tract, which can help improve symptoms associated with these diseases.
Purity ≥ 97 %:
In the pharmaceutical industry, purity is defined as the percentage of active ingredients in a given drug substance. Purity is an important factor while manufacturing drugs and other chemical compounds. It helps in maintaining the quality and efficacy of final products by avoiding any contamination or adulteration during production procedures.
Purity ≥ 98 %:
It has anti-inflammatory & immune modulating properties and can be used in the treatment of inflammatory bowel disease, rheumatoid arthritis and cancer. The demand for mesalamine is expected to witness growth over the forecast period owing to its increasing application in pharmaceuticals as well as biotechnology industries.
Application Insights:
Mesalamine capsules held the largest revenue share of over 40.0% in 2017 in terms of value as well as volume. The product is used for the treatment of allergic rhinitis and other nasal conditions, such as sinusitis, nasal polyps and allergies. Its high demand can be attributed to its effectiveness in treating these disorders along with its wide range of applications across various indications.
The tablets are available in low dose formulations (2 mg/tab) for patients requiring minimal systemic exposure while receiving mesalamine therapy at home without any additional medical professional supervision or monitoring required during treatment course with this drug API¢â‚¬â„¢s availability at affordable prices coupled with rising usage rates are expected to drive market growth over the forecast period 1 ¢â‚¬Å“ 2 [For detailed information see Mesalamine Capsules below.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period owing to increasing product demand from various end-use industries, such as animal health and nutrition, human health and pharmaceuticals. In addition, rising incidence of chronic diseases has led to an increase in the number of prescriptions for mesalamine tablets. This factor is anticipated to fuel regional growth over the forecast period.
Asia Pacific market for mesalamine API is expected to witness lucrative growth over the projected period owing to rapid economic development coupled with increased healthcare spending by governments across emerging countries such as China and India. These factors are likely contribute towards a rise in demand for generic drugs which will further boost industry expansion over next eight years (2018– 2030).
Growth Factors:
- Increasing incidence of Crohn's disease and ulcerative colitis
- Growing demand for novel therapies to treat inflammatory bowel diseases (IBD)
- Rising awareness about the benefits of mesalamine therapy over other treatment options
- Technological advancements in drug delivery systems that improve patient compliance
- Availability of generic versions of mesalamine API
Scope Of The Report
Report Attributes
Report Details
Report Title
Mesalamine API Market Research Report
By Type
Purity ≥ 97 %, Purity ≥ 98 %, Purity ≥ 99 %
By Application
Mesalamine Tablets, Mesalamine Capsules, Others
By Companies
Syntese A/S, Divis Laboratories, Cambrex Corporation, Ipca Laboratories, PharmaZell, Lasa Loboratory, Erregierre SpA, Corden Pharma Bergamo, CTX Lifescience, Ishita Active Pharma Ingredients, Syntese A/S, Xinxiang Tianfeng Fine Chemical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Mesalamine API Market Report Segments:
The global Mesalamine API market is segmented on the basis of:
Types
Purity ≥ 97 %, Purity ≥ 98 %, Purity ≥ 99 %
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Mesalamine Tablets, Mesalamine Capsules, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Syntese A/S
- Divis Laboratories
- Cambrex Corporation
- Ipca Laboratories
- PharmaZell
- Lasa Loboratory
- Erregierre SpA
- Corden Pharma Bergamo
- CTX Lifescience
- Ishita Active Pharma Ingredients
- Syntese A/S
- Xinxiang Tianfeng Fine Chemical
Highlights of The Mesalamine API Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Purity ≥ 97 %
- Purity ≥ 98 %
- Purity ≥ 99 %
- By Application:
- Mesalamine Tablets
- Mesalamine Capsules
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Mesalamine API Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Mesalamine API is a medication used to treat inflammation and pain. It is also used to prevent organ rejection after kidney transplantation.
Some of the key players operating in the mesalamine api market are Syntese A/S, Divis Laboratories, Cambrex Corporation, Ipca Laboratories, PharmaZell, Lasa Loboratory, Erregierre SpA, Corden Pharma Bergamo, CTX Lifescience, Ishita Active Pharma Ingredients, Syntese A/S, Xinxiang Tianfeng Fine Chemical.
The mesalamine api market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Mesalamine API Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Mesalamine API Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Mesalamine API Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Mesalamine API Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Mesalamine API Market Size & Forecast, 2018-2028
4.5.1 Mesalamine API Market Size and Y-o-Y Growth
4.5.2 Mesalamine API Market Absolute $ Opportunity
Chapter 5 Global Mesalamine API Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Mesalamine API Market Size Forecast by Type
5.2.1 Purity ≥ 97 %
5.2.2 Purity ≥ 98 %
5.2.3 Purity ≥ 99 %
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Mesalamine API Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Mesalamine API Market Size Forecast by Applications
6.2.1 Mesalamine Tablets
6.2.2 Mesalamine Capsules
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Mesalamine API Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Mesalamine API Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Mesalamine API Analysis and Forecast
9.1 Introduction
9.2 North America Mesalamine API Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Mesalamine API Market Size Forecast by Type
9.6.1 Purity ≥ 97 %
9.6.2 Purity ≥ 98 %
9.6.3 Purity ≥ 99 %
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Mesalamine API Market Size Forecast by Applications
9.10.1 Mesalamine Tablets
9.10.2 Mesalamine Capsules
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Mesalamine API Analysis and Forecast
10.1 Introduction
10.2 Europe Mesalamine API Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Mesalamine API Market Size Forecast by Type
10.6.1 Purity ≥ 97 %
10.6.2 Purity ≥ 98 %
10.6.3 Purity ≥ 99 %
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Mesalamine API Market Size Forecast by Applications
10.10.1 Mesalamine Tablets
10.10.2 Mesalamine Capsules
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Mesalamine API Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Mesalamine API Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Mesalamine API Market Size Forecast by Type
11.6.1 Purity ≥ 97 %
11.6.2 Purity ≥ 98 %
11.6.3 Purity ≥ 99 %
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Mesalamine API Market Size Forecast by Applications
11.10.1 Mesalamine Tablets
11.10.2 Mesalamine Capsules
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Mesalamine API Analysis and Forecast
12.1 Introduction
12.2 Latin America Mesalamine API Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Mesalamine API Market Size Forecast by Type
12.6.1 Purity ≥ 97 %
12.6.2 Purity ≥ 98 %
12.6.3 Purity ≥ 99 %
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Mesalamine API Market Size Forecast by Applications
12.10.1 Mesalamine Tablets
12.10.2 Mesalamine Capsules
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Mesalamine API Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Mesalamine API Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Mesalamine API Market Size Forecast by Type
13.6.1 Purity ≥ 97 %
13.6.2 Purity ≥ 98 %
13.6.3 Purity ≥ 99 %
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Mesalamine API Market Size Forecast by Applications
13.10.1 Mesalamine Tablets
13.10.2 Mesalamine Capsules
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Mesalamine API Market: Competitive Dashboard
14.2 Global Mesalamine API Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Syntese A/S
14.3.2 Divis Laboratories
14.3.3 Cambrex Corporation
14.3.4 Ipca Laboratories
14.3.5 PharmaZell
14.3.6 Lasa Loboratory
14.3.7 Erregierre SpA
14.3.8 Corden Pharma Bergamo
14.3.9 CTX Lifescience
14.3.10 Ishita Active Pharma Ingredients
14.3.11 Syntese A/S
14.3.12 Xinxiang Tianfeng Fine Chemical
